Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07082504

Effects of Exercise, Cognitive Training, and Their Combination in Institutionalized Older Adults

The goal of this clinical trial is to learn if physical exercise, cognitive stimulation, or a combination of both can improve mobility, cognitive function, and psychosocial well-being in institutionalized older adults aged 65 and older. The main questions it aims to answer are:

* Does physical exercise improve strength, flexibility, balance, and mobility? * Does cognitive stimulation improve executive function and mental state? * Does combining both interventions provide greater benefits than either intervention alone?

Researchers will compare the physical exercise group, the cognitive stimulation group, and the combined group to a control group that receives no active intervention to see which approach leads to the most improvement.

Participants will:

* Take part in either physical exercise, cognitive stimulation, or both, 3 times per week for 12 weeks * Complete assessments before the intervention, after 12 weeks, and again after 6 months * Answer questionnaires and perform physical and cognitive tests to measure changes in health and well-being

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals of both sexes.
  • Age 65 years or older.
  • Retired.
  • Institutionalized for more than three months.
  • Provide informed consent and agree to participate.

Exclusion criteria

  • Lack of cooperation or cognitive capacity to participate.
  • Diagnosis of dementia or Alzheimer's disease.
  • Presence of acute medical conditions.
  • Physical or cognitive impairments that prevent completion of study procedures.

Treatment and study plan

physical exercise program

Behavioral

Participants will complete supervised moderate-intensity physical exercise sessions three times per week for 12 weeks (totaling 150 minutes per week). The program includes balance, flexibility, strength, and mobility exercises designed according to WHO and ACSM guidelines for older adults. Sessions are delivered in small groups by trained physiotherapists.

Cognitive stimulation program

Behavioral

Participants will attend cognitive stimulation sessions three times per week for 12 weeks. Activities include memory games, attention tasks, puzzles, orientation exercises, and problem-solving strategies. The sessions are led by a psychologist and a trained social educator, in small groups.

Combined Physical Exercise and Cognitive Stimulation

Behavioral

Participants will receive both the physical exercise and cognitive stimulation interventions, conducted in parallel, over a 12-week period with three sessions per week. The combined program aims to improve physical and cognitive functions simultaneously and is delivered by a multidisciplinary team.

Primary outcomes

  1. Change from Baseline in Functional Mobility Measured by the Timed Up and Go (TUG) Test at 12 Weeks

    Time frame: From baseline to the end of the intervention at 12 weeks.

    Functional mobility will be assessed using the Timed Up and Go (TUG) test. The participant is timed while rising from a chair, walking 3 meters, turning, returning, and sitting.

    Score: Time in seconds (lower values indicate better mobility).

  2. Change from Baseline in Executive Function Assessed by the Stroop Test at 12 Weeks

    Time frame: From baseline to the end of the intervention at 12 weeks.

    Executive function will be assessed using the Stroop Color and Word Test, which evaluates attention, inhibition, and cognitive flexibility.

    Score: Time (seconds) and error count; lower values indicate better performance.

  3. Change from Baseline in Quality of Life Measured by EQ-5D at 12 Weeks

    Time frame: From baseline to the end of the intervention at 12 weeks.

    The EQ-5D assesses five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.

    Score Range: -0.594 to 1. Higher scores indicate better quality of life.

Secondary outcomes

  1. Change in Balance Performance Measured by the Tinetti Performance Oriented Mobility Assessment (POMA) at 12 Weeks

    Time frame: From baseline to the end of the intervention at 12 weeks.

    Balance will be evaluated using the Tinetti POMA. Score Range: 0-28 points. Higher scores indicate better balance and lower risk of falls.

  2. Change in Lower Body Strength Measured by the 30-Second Chair Stand Test at 12 Weeks

    Time frame: From baseline to the end of the intervention at 12 weeks.

    Participants will perform as many full stands as possible from a seated position in 30 seconds.

    Score: Number of stands. Higher numbers indicate better strength.

  3. Change in Upper Body Strength Measured by the Arm Curl Test at 12 Weeks

    Time frame: From baseline to 12 weeks post-intervention.

    Upper body strength is assessed by the number of bicep curls in 30 seconds using a standardized weight (5 lbs for women, 8 lbs for men).

    Score: Number of repetitions. Higher scores indicate better strength.

  4. Change in Grip Strength Measured by Hand Dynamometer at 12 Weeks

    Time frame: From baseline to 12 weeks post-intervention.

    Grip strength is measured using a handheld dynamometer. Score: Kilograms (kg). Higher scores indicate stronger grip.

  5. Change in Sleep Quality Measured by the Pittsburgh Sleep Quality Index (PSQI) at 12 Weeks

    Time frame: From baseline to the end of the intervention at 12 weeks.

    SThe PSQI evaluates sleep duration, disturbances, latency, and overall quality. Score Range: 0-21. Lower scores indicate better sleep quality.

  6. Change in Depressive Symptoms Measured by the Geriatric Depression Scale (GDS) at 12 Weeks

    Time frame: From baseline to the end of the intervention at 12 weeks.

    The GDS is a screening tool for depression in older adults. Score Range: 0-15. Lower scores indicate fewer depressive symptoms.

  7. Change in Life Satisfaction Measured by the Satisfaction With Life Scale (SWLS) at 12 Weeks

    Time frame: From baseline to the end of the intervention at 12 weeks.

    The SWLS measures global cognitive judgments of satisfaction with life. Score Range: 5-35. Higher scores indicate greater life satisfaction.

  8. Change in Functional Mobility Measured by the Timed Up and Go (TUG) Test at 6-Month Follow-Up

    Time frame: From the end of the intervention to 6 months follow-up.

    Follow-up assessment of mobility using the TUG test.

  9. Change in Executive Function Measured by the Stroop Test at 6-Month Follow-Up

    Time frame: From baseline to the end of the intervention at 12 weeks.

    Follow-up assessment of executive function using the Stroop Test.

  10. Change in Quality of Life Measured by the EQ-5D at 6-Month Follow-Up

    Time frame: From end of intervention to 6 months post-intervention.

    Follow-up assessment using the EuroQol-5 Dimension (EQ-5D).

Study contacts

Contact information is provided by the study sponsor or research team.

Nuno S. Carvalho, Master

CONTACT

[email protected]

0035-932364371

Sponsors and collaborators

Lead sponsor

University of Salamanca

Other

Registry information

Official study title

Effects of Physical Exercise Programs, Cognitive Stimulation, and Their Combination on Mobility, Cognitive Function, and Psychosocial Well-Being in Institutionalized Older Adults

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Jul 24, 2025
Registry last updated
Jul 10, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.